JESSICA GONZALEZ: Open Payments
NPI 1689160756 · SANTA FE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,320 in 41 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $302 · 2025 $1,320
Food & beverage: $1,310Speaker / faculty: $10
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 15 | $881 |
| ABBVIE INC. | 15 | $156 |
| Janssen Biotech, Inc. | 3 | $85 |
| UCB, Inc. | 2 | $69 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Lilly USA, LLC | 2 | $33 |
| GENZYME CORPORATION | 1 | $26 |
| Incyte Corporation | 1 | $17 |
Products named: DAXXIFY, SKYRIZI, TREMFYA, Bimzelx, RINVOQ, COSENTYX, DUPIXENT, Rhapsido.
Industry payments across NM — which companies pay providers there.
